Imidazopyridazine compounds

US7612067B2 · kind B2 · utility

Assignee

• ELI LILLY AND COMPANY · US

Inventors

• Heather Janelle Barbosa · Indianapolis, US
• Elizabeth Aaron Collins · Edinburgh, US
• Chafiq Hamdouchi · Carmel, US
• Erik James Hembre · Indianapolis, US
• Philip Arthur Hipskind · New Palestine, US
• Richard Duane Johnston · Greenfield, US
• Jianliang Lu · Fishers, US
• Michael John Rupp · Lake Bluff, US
• Takako Takakuwa · Indianapolis, US
• Richard Thompson · Frankfort, US

Key dates

• Filing date: Mar 20, 2006
• Grant date: Nov 3, 2009
• Expiry date: Mar 20, 2026

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to novel substituted imidazo[1,2-b]pyridazine compounds of Formula (I): pharmaceutical compositions thereof, and the use such compounds as corticotropin releasing factor 1 (CRF1) receptor antagonists in the treatment of psychiatric disorders and neurological diseases.